YIH
FATE icon

Y-Intercept (HK)’s Fate Therapeutics FATE Stock Holding History

Y-Intercept (HK)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
+44,773
New +$82.9K ﹤0.01% 1600
2025
Q1 		– Sell
-35,360
Closed -$58.3K – 1322
2024
Q4 		$58.3K Buy
+35,360
New +$89.1K ﹤0.01% 1116
2024
Q3 		– Sell
-17,053
Closed -$55.9K – 1472
2024
Q2 		$55.9K Buy
+17,053
New +$74.7K ﹤0.01% 1296
2023
Q4 		– Sell
-95,698
Closed -$203K – 1360
2023
Q3 		$203K Buy
95,698
+63,116
+194% +$209K 0.02% 910
2023
Q2 		$155K Buy
+32,582
New +$180K 0.02% 978
2021
Q4 		– Sell
-6,376
Closed -$378K – 670
2021
Q3 		$378K Buy
6,376
+1,248
+24% +$97.9K 0.07% 410
2021
Q2 		$445K Buy
+5,128
New +$413K 0.11% 293

Other funds holding FATE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $454M AUM 31.05% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return